Company Profile

Surgalign Holdings, Inc. is a medical technology company. The Company is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.

Employees

240

Sector

Advanced Medical Equipment & Technology

More about the company

23-10-22	Xtant Medical Holdings, Inc. acquired NanOss Production Operations of RTI Surgical, Inc. for $2.2 million.	CI
23-10-02	Surgalign Holdings, Inc. Emerged from Bankruptcy	CI
23-09-27	Combined Hearing for Disclosure Statement and Plan Approved for Surgalign Holdings, Inc.	CI
23-09-01	Fourth Amended Reorganization Plan and Disclsoure Statement Filed by Surgalign Holdings, Inc.	CI
23-08-31	Third Amended Reorganization Plan and Disclosure Statement Filed by Surgalign Holdings, Inc.	CI
23-08-31	Modified Disclosure Statement Conditionally Approved for Surgalign Holdings, Inc.	CI
23-08-31	First Amended Reorganization Plan and Disclosure Statement Filed by Surgalign Holdings, Inc.	CI
23-08-29	Second Amended Reorganization Plan and Disclosure Statement Filed by Surgalign Holdings, Inc.	CI
23-08-29	Combined Reorganization Joint Plan and Disclosure Statement Filed by Surgalign Holdings, Inc.	CI
23-08-10	Augmedics, Inc. acquired Digital Health Assets from Surgalign Holdings, Inc. (OTCPK:SRGA.Q) for $1.5 million.	CI
23-08-10	Xtant Medical Closes Acquisition of Surgalign's Hardware, Biologics Business; Shares Surge After Hours	MT
23-08-10	Motion for Asset Sale Approved for Surgalign Holdings, Inc.	CI
23-08-09	Xtant Medical Holdings, Inc. completed the acquisition of Certain assets from Surgalign Holdings, Inc..	CI

23-03-31	Craig-Hallum Adjusts Price Target on Surgalign Holdings to $2 From $5, Maintains Hold Rating	MT
22-12-21	HC Wainwright Initiates Surgalign With Buy Rating, Price Target is $3.50	MT
22-03-10	Cantor Fitzgerald Reinstates Surgalign Holdings With Overweight Rating	MT
21-09-28	SURGALIGN : Craig-Hallum Downgrades Surgalign Holdings to Hold from Buy, Adjusts Price Target to $1.50 From $3	MT
21-08-09	SURGALIGN : Craig-Hallum Adjusts Surgalign Holdings' Price Target to $3 from $5, Keeps Buy Rating	MT

24-07-10	Surgalign : RTI Surgical appoints Chad Croasdale as Chief Commercial Officer	PU
23-11-28	RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva Allograft Dermis in Breast Reconstruction	AQ
23-11-26	Surgalign : RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction	PU
23-09-29	Surgalign : Bankruptcy - Form 8-K	PU
23-07-28	Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales	GL

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/15/23	David Lyle	Tax	Chief Financial Officer	1,329	0.0145%
9/1/23	Paolo Amoruso	Tax	General Counsel	2,191	0.0239%
8/15/23	Enrico Sangiorgio	Tax	EVP, International	5,541	0.0603%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SURGALIGN HOLDINGS, INC.	+32.35%	+32.35%	-	-	165K
VEEVA SYSTEMS INC.	+3.35%	+5.46%	-29.18%	-3.30%	31.46B
PRO MEDICUS LIMITED	+0.62%	-8.64%	-40.32%	+195.94%	14.08B
SECTRA AB	-1.06%	-1.90%	-23.38%	+69.11%	5.65B
HEARTFLOW, INC.	-2.46%	-3.64%	-	-	2.35B
OMNICELL, INC.	+2.18%	+4.57%	+71.62%	-33.18%	2.13B
GENERATE BIOMEDICINES, INC.	-3.91%	-14.38%	-	-	1.8B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	+3.15%	+1.69%	-32.76%	-	1.08B
ARBUTUS BIOPHARMA CORPORATION	+5.59%	-6.71%	+53.19%	+113.11%	901M
RAYSEARCH LABORATORIES AB	-19.62%	-22.87%	-50.37%	+169.37%	795M
Average	+2.07%	-3.11%	-7.31%	+85.18%	6.69B
Weighted average by Cap.	+1.47%	-2.20%	-26.61%	+58.38%

Surgalign Holdings, Inc. Stock

Stocks

SRGA

US86882C2044

Advanced Medical Equipment & Technology

Latest news : Surgalign Holdings, Inc.

Analysts' recommendations: Surgalign Holdings, Inc.

Press Releases: Surgalign Holdings, Inc.

Quotes and Performance

Latest insider transactions

Medical Software & Technology Services

Company Profile